BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38411285)

  • 1. Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations.
    Amano H; Uchida H; Harada K; Narita A; Fumino S; Yamada Y; Kumano S; Abe M; Ishigaki T; Sakairi M; Shirota C; Tainaka T; Sumida W; Yokota K; Makita S; Karakawa S; Mitani Y; Matsumoto S; Tomioka Y; Muramatsu H; Nishio N; Osawa T; Taguri M; Koh K; Tajiri T; Kato M; Matsumoto K; Takahashi Y; Hinoki A
    Cancer Sci; 2024 May; 115(5):1634-1645. PubMed ID: 38411285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.
    Matser YAH; Verly IRN; van der Ham M; de Sain-van der Velden MGM; Verhoeven-Duif NM; Ash S; Cangemi G; Barco S; Popovic MB; van Kuilenburg ABP; Tytgat GAM;
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30289. PubMed ID: 37010353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients.
    Verly IR; van Kuilenburg AB; Abeling NG; Goorden SM; Fiocco M; Vaz FM; van Noesel MM; Zwaan CM; Kaspers GL; Merks JH; Caron HN; Tytgat GA
    Eur J Cancer; 2017 Feb; 72():235-243. PubMed ID: 28061374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
    Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
    Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrine.
    Peitzsch M; Butch ER; Lovorn E; Mangelis A; Furman WL; Santana VM; Hero B; Berthold F; Shulkin BL; Huebner A; Eisenhofer G
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28081. PubMed ID: 31724812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal activity may predict aggressive behavior in neuroblastoma.
    Zambrano E; Reyes-Múgica M
    Pediatr Dev Pathol; 2002; 5(2):190-9. PubMed ID: 11910515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA.
    Yokomori K; Hori T; Tsuchida Y; Kuroda M; Yoshioka M
    J Pediatr Surg; 1989 Apr; 24(4):391-4. PubMed ID: 2659761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of an LC-MS/MS Method for the Simultaneous Quantification of Homovanillic Acid and Vanillylmandelic Acid for the Diagnosis and Follow-Up of Neuroblastoma in 357 Patients.
    Hwang N; Chong E; Oh H; Cho HW; Lee JW; Sung KW; Lee SY
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34200415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-quantitative detection of a vanillactic acid/vanillylmandelic acid ratio in urine is a reliable diagnostic marker for aromatic L-amino acid decarboxylase deficiency.
    Brennenstuhl H; Garbade SF; Okun JG; Feyh P; Hoffmann GF; Langhans CD; Opladen T
    Mol Genet Metab; 2020; 131(1-2):163-170. PubMed ID: 32675002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
    Sadilkova K; Dugaw K; Benjamin D; Jack RM
    Clin Chim Acta; 2013 Sep; 424():253-7. PubMed ID: 23830883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of Neuroblastoma Markers Homovanillic Acid (HVA) and Vanillylmandelic Acid (VMA) in Urine by Gas Chromatography-Mass Spectrometry (GC/MS).
    Beals M; Ramoo B; Clinton Frazee C; Garg U
    Methods Mol Biol; 2022; 2546():185-194. PubMed ID: 36127589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacterial contamination of infant urine samples obtained from filter papers used in neuroblastoma-screening tests. (6) Protective effects of preaddition of chlorhexidine digluconate in filter papers or containers for urine on bacterial break-down of creatinine, vanillylmandelic acid and homovanillic acid].
    Imai J; Iwata H; Gotoh K; Mori H; Kawai M
    Nihon Koshu Eisei Zasshi; 1992 Oct; 39(10):789-98. PubMed ID: 1467545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple dilute-and-shoot method for urinary vanillylmandelic acid and homovanillic acid by liquid chromatography tandem mass spectrometry.
    Clark ZD; Cutler JM; Pavlov IY; Strathmann FG; Frank EL
    Clin Chim Acta; 2017 May; 468():201-208. PubMed ID: 28263737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of catecholamine metabolites as endogenous population biomarkers for wastewater-based epidemiology.
    Pandopulos AJ; Bade R; Tscharke BJ; O'Brien JW; Simpson BS; White JM; Gerber C
    Sci Total Environ; 2021 Apr; 763():142992. PubMed ID: 33498117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
    Fauler G; Leis HJ; Huber E; Schellauf C; Kerbl R; Urban C; Gleispach H
    J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers.
    Lam L; Woollard GA; Teague L; Davidson JS
    Ann Clin Biochem; 2017 Mar; 54(2):264-272. PubMed ID: 27235704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
    Sato Y; Hanai J; Takasugi N; Takeda T
    Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
    Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
    Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
    Tuchman M; Stoeckeler JS
    Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.